The US Has the Highest Healthcare Spending in the World and Among the Worst Outcomes

The United States spends approximately $12,500 per person per year on healthcare. The next highest spenders — Switzerland, Germany, Norway — spend roughly $8,000 to $9,000. Countries with universal systems like Canada, Australia, and the United Kingdom spend between $5,000 and $7,000. American healthcare spending is not modestly higher. It is in a category of its own. The outcomes, by contrast, are not.

What the Numbers Show

The Commonwealth Fund's 2023 international health system report compared the United States against ten peer nations on measures including life expectancy, infant mortality, preventable deaths, avoidable hospitalizations, and chronic disease management. The US ranked last overall. It ranked last on health outcomes specifically. It ranked last on access, equity, and care process — though it ranked first on care quality for patients who receive it. That last distinction is important and worth holding onto. American medicine, at its best, is extraordinary. The hospitals are well-equipped. The specialists are among the most skilled in the world. The pharmaceutical pipeline produces innovations that reach American patients years before they reach patients elsewhere. The problem is not the quality of care available. The problem is the architecture of who receives it and when.

The Access Gap

Researchers at Harvard Medical School studying mortality attributable to lack of insurance estimated that approximately 68,000 Americans die annually from causes directly linked to insurance gaps — conditions that would have been treatable or manageable with earlier access to care. These are not deaths from conditions for which medicine has no answer. They are deaths from delayed diagnosis, deferred treatment, and the accumulated consequences of using emergency rooms as primary care. This figure is contested. Methodological debates about how to isolate insurance status as a cause of death are legitimate. But the directional finding — that Americans without reliable insurance access die earlier from preventable causes — is consistent across decades of research and is not seriously disputed in the epidemiological literature.

Where the Money Goes

If the spending is the highest in the world and the outcomes are not, where does the money go? The answer is administrative cost, provider compensation differentials, pharmaceutical pricing, and the transaction costs of a system with hundreds of payers negotiating hundreds of different contracts with hundreds of provider networks. A study published in the New England Journal of Medicine estimated that administrative costs account for roughly 34 percent of total US healthcare expenditure — compared to 12 percent in Canada and 25 percent in Germany. The difference is largely attributable to billing complexity. Every insurer has different codes, different authorization requirements, different fee schedules. Hospitals and physician practices employ large administrative staffs simply to navigate the billing environment. That cost goes into the spending figure. It does not produce a single unit of care.

The Perverse Logic of Downstream Treatment

Here is the dynamic that explains much of the outcomes gap. American healthcare is organized around treatment rather than prevention. Patients without consistent primary care access accumulate unmanaged risk — uncontrolled hypertension, unmonitored diabetes, untreated depression — until a crisis point requires expensive intervention. That expensive intervention shows up in the spending numbers. The years of foregone primary care that preceded it mostly do not. Countries with universal primary care access produce different patterns. Patients see physicians earlier, conditions are caught at treatable stages, and expensive hospitalizations are avoided. The savings from avoided hospitalization partially offset the cost of expanded primary access. The net effect is lower per-capita spending and better outcomes. This is not a theoretical model. It is what the data from peer nations shows, consistently, across different healthcare system designs.

The Political Difficulty

None of this is news to anyone who works in healthcare policy. The structural diagnosis has been available for decades. The political obstacle is the constituency structure around the existing system. Insurers, pharmaceutical companies, hospital systems, and medical device manufacturers generate enormous revenues under current arrangements. The administrative complexity that consumes 34 cents of every healthcare dollar employs hundreds of thousands of billing specialists, coders, and claims processors. Reform that produces efficiency also produces job losses and revenue reductions in sectors with significant political influence. The worst outcomes in the developed world are, in a real sense, the price of a political equilibrium.